Elizabeth Moore
Papers
1
Total Citations
109
H-Index
1
About
Dr. Elizabeth Moore is a leading translational scientist whose work centers on liquid biopsy technologies for noninvasive cancer management, with a particular focus on the pre-analytical variables that govern circulating tumor DNA (ctDNA) detection. Her landmark 2018 study, “Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients,” has garnered 109 citations and remains a cornerstone reference in the field. In this work, Moore systematically demonstrated how common pre-analytical factors—such as blood collection tubes, processing delays, and centrifugation protocols—can dramatically elevate total cell-free DNA (cfDNA) levels through leukocyte lysis, thereby obscuring the tumor-derived signal. By establishing rigorous standardized protocols, she provided the critical methodological framework that enables reliable ctDNA analysis in clinical settings. Her contributions have directly shaped best practices in liquid biopsy workflows, making her research indispensable for oncologists and translational researchers seeking to harness ctDNA for early detection, treatment monitoring, and minimal residual disease assessment. Dr. Moore’s work bridges the gap between bench and bedside, ensuring that the promise of precision oncology is built on a foundation of reproducible, high-quality data.
Research Focus
Key Achievements
Top Papers
- 1